Pharmacy-based Point-of-Care Testing Certificate Program

Upcoming Dates

December 7, 2021 (Virtual)
9 a.m. – 1 p.m. ET

Program Information

The NASPA Pharmacy-based Point-of-Care Testing Certificate Program provides an opportunity to gain the skills and information necessary to develop a testing program for coronaviruses, influenza, Group A Streptococcus, HIV, and Hepatitis C. The target is pharmacists, pharmacy technicians, and student pharmacists.

The 20-hour ACPE-accredited certificate program includes comprehensive material regarding key disease states, physical assessment, point-of-care tests, collaborative practice models, and business models through:

  • 16 hours of home study

  • Up to 4 hours of live, virtual training

  • 15 minute virtual skills assessment based on your availability (a few basic supplies needed)

Students take an online assessment after each of the 12 modules of home study, in addition to a cumulative assessment (must pass 70% within three attempts). Then, proficiency to conduct physical assessments and offer point-of-care testing services is assessed after the live training during the virtual skills assessment.

Upon successful completion of all three portions of the program and all program evaluations, participants are awarded a certificate of completion and pharmacists can receive 20 hours of Continuing Pharmacy Education (CPE) credit.

Learning Objectives

At the completion of this activity, the pharmacist will be able to:

  • Identify at least 3 opportunities for expanding patient-centered services in the community pharmacy setting, using point of care

  • Discuss the value and limitations of patient reported symptoms, medical history, and drug allergies

  • Describe and perform the following physical assessments, when appropriate to patient care: Blood Pressure, Pulse, Respiratory Rate, Oxygenation, Cervical Lymph Node Inspection, Body Temperature

  • Describe and perform the following specimen collections used in point of care testing: Throat swab, Oral fluid collection, Nasal swab, Finger stick

  • Identify characteristics of the five exemplar infectious diseases (influenza, Group A Streptococcus, Human Immunodeficiency Virus, Hepatitis C, Coronaviruses) regarding: Causative agents, Transmission, Immunizations, Symptoms and Presentation, Appropriate therapy, Point-of-Care testing

  • Define and contrast the following terms as they relate to point-of-care testing in community pharmacies: CLIA, CLIA-waived, Collaborative Agreement, Protocol, Prescribe, Diagnose

  • Explain the value and limitations of Point-of-Care Tests, including rapid diagnostic tests, and list the steps a pharmacist can take to improve test performance

  • Apply all information to patient-specific cases based on common community pharmacy-based patient interaction

At the completion of this activity, the pharmacy technician will be able to:

  • Identify at least 3 opportunities for expanding patient-centered services in the community pharmacy setting, using point of care

  • Discuss the value and limitations of patient reported symptoms, medical history, and drug allergies

  • Describe and perform the following physical assessments, when appropriate to patient care: Blood Pressure, Pulse, Respiratory Rate, Oxygenation, Cervical Lymph Node Inspection, Body Temperature

  • Describe and perform the following specimen collections used in point of care testing: Throat swab, Oral fluid collection, Nasal swab, Finger stick

  • Identify signs, symptoms, and characteristics of the five exemplar infectious diseases (influenza, Group A Streptococcus, Human Immunodeficiency Virus, Hepatitis C, Coronaviruses) where POCT may be relevant

  • Define and contrast the following terms as they relate to point-of-care testing in community pharmacies: CLIA, CLIA-waived, Collaborative Agreement, Protocol, Prescribe, Diagnose

  • Explain the value and limitations of Point-of-Care Tests, including rapid diagnostic tests, and list the steps a pharmacist can take to improve test performance

  • Apply all information to patient-specific cases based on common community pharmacy-based patient interactions

Speakers:
Kevin Day, PharmD, owner, President, Day’s Miami Heights Pharmacy, Cincinnati, Ohio
John Beckner, RPh, NCPA Senior Director of Strategic Initiatives, Alexandria, Va.

NOTE: The NASPA Point of Care Testing Certificate Program does not meet the requirements of the Florida Board of Pharmacy’s rules for Test and Treat certification or continuing education programs for Florida pharmacists and pharmacy technicians.

Questions? Email Shantel Houston, PharmD

ACPEMichigan Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Credit is only awarded for completion of the entire 20 contact hour program. Credit must be claimed within 60 days of completing the program.

Pharmacy-based Point-of-Care Testing Certificate Program

ACPE Universal Activity #0112-0000-21-112-B04-P | 0112-0000-21-112-B04-T.
Activity Type: Practice-based
Target Audience: Pharmacists and pharmacy technicians in all practice settings
Release Date: February 4, 2021
Expiration Date: February 4, 2024

Contact Hours: 20.0

Minimum System Requirements
Processor: 1GHz | Hard Drive: 32 GB | Memory (RAM): 1 GB | Sound card with speakers | Internet Access: 10 Mbps download

Supported Browsers
Latest Chrome Version | Latest Firefox Version | Latest Edge Version | Latest Safari Version | Internet Explorer 11